Can IBD patients take less medicine? new study aims to find out
NCT ID NCT07303686
Summary
This study is testing whether patients with Crohn's disease or ulcerative colitis who are in deep remission can safely reduce the frequency of their ustekinumab injections. Researchers want to see if patients can space out their shots from every 4 weeks to every 8 weeks, or from every 8 weeks to every 12 weeks, without their symptoms returning. They will monitor patients for a year to check their health and inflammation levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MUHC - Montreal General Hospital
RECRUITINGMontreal, Quebec, H3G1A4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.